Fuhrer has over 12 years experience directing teams of scientists and technicians in large pharmaceutical companies, biotech organisations and CROs. Fuhrer has experience in therapeutic areas like anti-infectives,
bitop’s present clinical study is a single-center efficacy and feasibility study involving patients with inflammation and airway obstruction in Germany. bitop said that after the successful feasibility a
Headquartered in Tampa, Florida, Biovest International, in collaboration with the National Cancer Institute, has developed a patient-specific, cancer vaccine, BiovaxID, with three clinical trials completed, including a Phase
The grants, which target therapeutic discovery projects that show a reasonable potential to result in new therapies to treat areas of unmet medical need or prevent or treat
NitroMist is NovaDel’s oral spray formulation of nitroglycerin, which has been approved by the FDA for acute relief of an attack of angina pectoris, or acute prophylaxis of
Emergent posted a net income of $13.12m for the third quarter 2010, or $0.41 per diluted share, compared to net loss of $3.95m, or $0.03 per diluted share,
Amylin has posted a net loss of $50.73m for the third quarter 2010, or $0.35 loss per diluted share, compared to net loss of $26.66m, or $0.19 loss
Watson has posted a net income of $25.7m for the third quarter 2010, or $0.21 per diluted share, compared to net income of $63m, or $0.55 per diluted
In the trial, people participated lived a median of 6.2 months without their disease getting worse (median progression-free survival or PFS). Almost 52% of patients in the trial
In addition to the technical and business advisory services, the funding will be used to conduct studies and determine efficacy, selectivity and pharmacokinetics properties for the development of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.